[1]
D. A. Al-Assaf and S. Y. Bede, “Changes of peri-implant bone density in relation to local application of alendronate and/or recombinant human bone morphogenetic protein-2: A randomized controlled clinical study”, J Osseointegr, vol. 14, no. 3, pp. 185–193, Sep. 2022.